SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Identix (IDNX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: brad greene who wrote (10958)10/23/1998 10:38:00 AM
From: Hockeyfan  Read Replies (1) of 26039
 
Time to play..where are they now?

IDID --- .25 cents per share, but with 600 million shares o/s they still have market cap of $1.6 million! Checked news to see lawsuit judgement against ex-CEO and board member on 8/20/98 forcing them to pay back all of their salaries and profits from stock sales. IDID went from 1/16 to over $1 7/8 in 3 days during May of 1996 creating a market cap of over $1 billion and setting all-time NASDAQ trading volume records.

EOSC -- 1/32 = 3.125 cents per share.

DDSI -- 30 cents per share.

SACM -- $3.00 per share.

NRID -- 65 cents per share.
Review of NRID's 3Q financials reveals:
- 3Q revenues of $437,000
- 3Q pfd stock dividends of $1,800,000
- cash of $88,000, investments of $306,000
- A/R of $947,000
- total current assets of $1.4 mm vs. current liabilities of $1.27 mm
- book value of 16 cents per share

Summary - NRID's business MAY be turning the corner, but their balance sheet is in such dire financial condition that they will need financing or a partner by 1Q99. Their current financing cost exceeds revenues, let alone profits, by a significant margin. The best thing that could happen to NRID shareholders is a quick buyout, otherwise they will face a long period of improving revenues but constantly negative bottom line and further share dilution.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext